Philip L S Jones

Cardiorenal outcomes, kidney function, and other safety outcomes with ertugliflozin in older adults with type 2 diabetes (VERTIS CV): secondary analyses from a randomised, double-blind trial.

C. Cannon, D. McGuire, R. Pratley, 2023, The lancet. Healthy longevity.